Navigation Links
DuPont Leaders Brief Investors on Agriculture Businesses
Date:8/19/2007

DuPont Science Addressing Increased Demand for Food, Feed, Fuel, Materials

DES MOINES, Iowa, Aug. 15 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) Chairman and CEO Charles O. Holliday, Jr., Executive Vice President & Chief Innovation Officer Thomas M. Connelly, and Group Vice President -- DuPont Agriculture & Nutrition J. Erik Fyrwald today updated investors on DuPont businesses serving the agriculture and biofuels markets.

"Global population growth, rising income and demand for biofuels is driving increased demand for agricultural outputs," Holliday said at the DuPont Global Agriculture Investors' Day. "DuPont is uniquely positioned to meet that challenge due to our multi-discipline science, ability to leverage that science across different industries, and our broad market access and global reach."

Connelly added, "The synergies among agricultural biotechnology, biofuels and biomaterials are creating potential game-changing solutions to the global challenges we face today and significant growth opportunities for DuPont."

The company's core competencies to drive innovation across a number of biotechnology markets include cell biology/physiology, molecular biology (gene discovery, expression and optimization), genomics, proteomics, biochemistry and metabolic engineering.

Noting that DuPont is using biotechnology to deliver advanced plant genetics along with chemistry to improve productivity, quality and yield, Fyrwald reviewed the platform's top pipeline candidates.

"We are advancing a rich pipeline of new products to enhance yield and nutrition," he said, referencing top-performing insect resistant corn, Rynaxypyr(TM) low-dosage insecticide, fungal resistant corn, Optimum(TM) GAT(TM) dual herbicide tolerance and healthier soybean oil.

To more strongly position itself for attractive agricultural markets, DuPont announced last year that it was investing $100 million in savings from a restructuring into its crop genetics research and seed sales and marketing.

"The growth fundamentals in seed markets around the world are outstanding," said Fyrwald. "As a result, we are accelerating our growth investments at a faster rate than the savings from our previously announced restructuring plan."

Approximately $100 million in growth investments will be made in 2007. The investments are targeted at accelerating new product launches, increasing the rate of genetic gain, expanding capacity for plant biotechnology discovery and development, increased sales coverage, and more aggressive promotions. With regard to savings from the restructure program, Fyrwald said DuPont Agriculture & Nutrition will generate savings of approximately $20 million of the $100 million target late in 2007, another $40 million in savings in 2008, and the remaining $40 million in savings in 2009.

Fyrwald noted that for the year 2007, he expects the DuPont Agriculture & Nutrition platform to deliver about 10 percent revenue growth and 20 percent pretax operating income (PTOI) growth before accounting for the accelerated growth investments. Including the investments, PTOI growth would be about 10 percent, compared to a compound annual average growth rate of 14 percent since 2001.

DuPont reaffirmed its outlook for 2007 full-year earnings per share of about $3.15, excluding a $0.06 per share charge for significant items in the first quarter 2007.

A replay of today's presentation and the question and answer session can be found at the Investor Center of the company's website at http://www.dupont.com. DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), Rynaxypyr(TM) and Optimum(TM) GAT(TM) are registered trademarks or trademarks of DuPont or its affiliates.


'/>"/>
SOURCE DuPont

Copyright©2007 PR Newswire.

Related biology technology :

1. CIO Leadership Series: Snap-Ons Moreno offers lessons in IT transformation
2. CIO Leadership Series: Logothetis likes CIOs evolving role
3. CIO Leadership Series: Phil Loftus, Aurora Health Care
4. CIO Leadership Series: Deb Rislow, Gundersen Lutheran
5. Patent ruling doesnt tarnish Wisconsins stem cell leadership
6. CIO Leadership Series: Judy Lemke, Schneider National
7. CIO Leadership Series: Tanya Townsend, Saint Clares Hospital
8. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
9. CIO Leadership Series: Rick Davidson, Manpower
10. CIO Leadership Series: Mike Sauk, UW Hospital and Clinics
11. CIO Leadership Series: Ed Meachen, University of Wisconsin System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):